References
  1. AUBAGIO® (teriflunomide) Product Monograph. Sanofi Genzyme, May 10, 2021.
  2. AVONEX® (interferon beta-1a) Product Monograph. Biogen Canada Inc., May 26, 2020.
  3. BETASERON® (interferon beta-1b) Product Monograph. Bayer Inc., August 10, 2021.
  4. COPAXONE® (glatiramer acetate injection) Product Monograph. Teva Canada Innovation, February 4, 2021.
  5. GILENYA® (fingolimod hydrochloride) Product Monograph. Novartis Pharmaceuticals Canada Inc., July 26, 2021
  6. GLATECT™ (glatiramer acetate injection) Product Monograph. Pharmascience Inc., March 10, 2021.
  7. KESIMPTA™ (ofatumumab) Product Monograph. Novartis Pharmaceuticals Canada Inc., January 22, 2021.
  8. LEMTRADA® (alemtuzumab) Product Monograph. Genzyme Canada, January 19, 2022
  9. MAVENCLAD® (cladribine) Product Monograph. EMD Serono, October 7, 2021
  10. OCREVUS® (ocrelizumab) Product Monograph. Hoffmann-La Roche Limited, April 1, 2021.
  11. PLEGRIDY® (peginterferon beta-1a) Product Monograph. Biogen Canada Inc., May 26, 2020.
  12. REBIF® (interferon beta-1a) Product Monograph. EMD Serono, February 6, 2020.
  13. TECFIDERATM (dimethyl fumarate) Product Monograph. Biogen Canada Inc., October 7, 2021.
  14. TYSABRI® (natalizumab) Product Monograph. Biogen Canada Inc., January 10, 2017.
  15. ZEPOSIA® (ozanimod hydrochloride) Product Monograph. Celgene Inc., April 7, 2022

AUBAGIO®, LEMTRADA® and MS One to One® are registered trademarks of Sanofi Genzyme Canada, a division of sanofi-aventis Canada Inc.
AVONEX®, PLEGRIDY®, TECFIDERA®, TYSABRI® and Biogen ONE®, are registered trademarks of Biogen Canada Inc.
BETASERON® and BetaPlus® are registered trademarks of Bayer Inc.
COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. and is used under licence. Shared Solutions® is a registered trademark of Teva Pharmaceutical Industries Ltd. and is used under licence. TEVA and the design version thereof are registered trademarks of Teva Pharmaceutical Industries Ltd. and are used under licence. GILENYA® is a registered trademark of Novartis Pharmaceuticals Canada Inc.
GILENYA® GO program™ is a trademark of Novartis Pharmaceuticals Canada Inc.